Cargando…
Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy
Colorectal cancer (CRC) patients are still lacking viable treatments. Chimeric antigen receptor (CAR) T cells have shown promise in hematologic malignancies, but their efficacy in solid tumors has been limited due to the immunosuppressive tumor microenvironment. We found that cancer antigen- EpCAM e...
Autores principales: | Li, Weizhen, Zhou, Yang, Wu, Zhongen, Shi, Yaoping, Tian, Enming, Zhu, Yingqi, Wang, Tao, Dou, Wei, Meng, Xiangjing, Chen, Ming, Zhai, Bo, Zhu, Di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591126/ https://www.ncbi.nlm.nih.gov/pubmed/34790117 http://dx.doi.org/10.3389/fphar.2021.724306 |
Ejemplares similares
-
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015) -
Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014) -
EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors
por: Li, Dan, et al.
Publicado: (2023) -
Expression of EpCAM in uveal melanoma
por: Odashiro, Danilo N, et al.
Publicado: (2006) -
Biology and clinical relevance of EpCAM
por: Keller, Laura, et al.
Publicado: (2019)